I n 1941, virologist George K. Hirst discovered that adding influenza virus to red blood cells (erythrocytes) in a test tube caused the cells to agglutinate, mediated by one of the virus surface glycoproteins, hemagglutinin (from the Greek haima, "blood," + Latin gluten, "glue"). Alfred Gottschalk later showed that hemagglutinin binds virus to host cells by attaching to sialic acids (from the Greek sialon, "saliva") on carbohydrate side chains of cell-surface glycoproteins and glycolipids. The other influenza virus surface protein, neuraminidase (referring to brain lipids from which it was first derived), is a virus receptor-destroying enzyme that removes its substrate, sialic acids, from infected cell surfaces so that newly made progeny viruses are released to infect additional cells. At present, 18 hemagglutinin subtypes (H1-H18) and 11 neuraminidase subtypes (N1-N11) are recognized. 
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